RBC Bioscience

RBC Bioscience Retained Earnings

The Retained Earnings of RBC Bioscience (6848.TWO) as of Nov 6, 2026 is 46.90 M TWD. In the previous year, Retained Earnings was 40.27 M TWD — a change of 16.48% (higher).

Retained Earnings

46.90 MTWD

YoY

16.48%

Last updated:

Retained Earnings of RBC Bioscience is 2024 46.90 M TWD. Retained Earnings of RBC Bioscience was 2023 40.27 M TWD. It decreases by 16.48% higher compared to the previous year.

The RBC Bioscience Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2018
13.51 M TWD
Jan 1, 2019
15.69 M TWD
Jan 1, 2020
95.31 M TWD
Jan 1, 2021
71.43 M TWD
Jan 1, 2022
48.75 M TWD
Jan 1, 2023
40.27 M TWD
Jan 1, 2024
46.90 M TWD
The RBC Bioscience Retained Earnings history
YEARRetained EarningsYoY
46.90 MTWD+16.48%
40.27 MTWD-17.40%
48.75 MTWD-31.76%
71.43 MTWD-25.06%
95.31 MTWD+507.33%
15.69 MTWD+16.13%
13.51 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Retained Earnings of RBC Bioscience is 46.90 M TWD in 2024.

Retained Earnings of RBC Bioscience changed from 40.27 M TWD to 46.90 M TWD, representing a 16.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — RBC Bioscience

All Key Metrics — RBC Bioscience